Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-044147
Filing Date
2024-04-12
Accepted
2024-04-12 17:23:46
Documents
18
Period of Report
2024-04-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A acet-20240412.htm   iXBRL PRE 14A 1310770
2 GRAPHIC img105727521_0.jpg GRAPHIC 3411
3 GRAPHIC img105727521_1.jpg GRAPHIC 3411
4 GRAPHIC img105727521_2.jpg GRAPHIC 21591
5 GRAPHIC img105727521_3.jpg GRAPHIC 22579
6 GRAPHIC img105727521_4.jpg GRAPHIC 92405
7 GRAPHIC img105727521_5.jpg GRAPHIC 66760
  Complete submission text file 0000950170-24-044147.txt   2664517

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20240412.xsd EX-101.SCH 40635
21 EXTRACTED XBRL INSTANCE DOCUMENT acet-20240412_htm.xml XML 241739
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38359 | Film No.: 24842470
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)